Skip to content

Low-Dose Chest Computed Tomography Screening for Lung Cancer in Survivors of Hodgkin's Disease

Low-Dose Chest Computed Tomography Screening for Lung Cancer in Survivors of Hodgkin's Disease

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00601146
Enrollment
39
Registered
2008-01-25
Start date
2006-11-01
Completion date
2019-12-01
Last updated
2020-01-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Lung Cancer

Keywords

Hodgkin's disease, CT scan

Brief summary

This research study is being done because patients with a history of chest radiation treatment for Hodgkin's disease have been shown to be at increased risk for developing lung cancer a number of years out from treatment. The risk appears to be further increased among patients with a smoking history. Currently, the practice is to recommend annual low-dose chest CT scans in survivors of Hodgkin's disease who have received prior chest radiation treatment and who have at least a moderate smoking history. In this study, the CT scans will be read and interpreted by the study radiologist, and the results recorded in a consistent manner.

Detailed description

\- Participants will undergo a chest computed tomography (CT) scan once a year for a 3-year period.

Interventions

Once a year for three years

Sponsors

Brigham and Women's Hospital
CollaboratorOTHER
Dana-Farber Cancer Institute
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
SCREENING
Masking
NONE

Intervention model description

Single arm study of low-dose Chest CT screening for long-term Hodgkin lymphoma survivors

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* 5 years or longer from initial Hodgkin's disease diagnosis * Current age 18 or older * Received mediastinal irradiation and/or alkylating-agent based chemotherapy * Smoking history of 10-pack years or more, or current smoker * Pre-approval from the participant's insurance company for the CT study

Exclusion criteria

* Patients with a history of lung cancer * Currently receiving treatment for another cancer diagnosis * Known diagnosis of any metastatic cancer * Pregnant women

Design outcomes

Primary

MeasureTime frameDescription
To Prospectively Collect Data on Chest CT Screening for Patients at Increase Lung-cancer Risk After Hodgkin's Disease.3 yearsIn this study, patients will under annual low-dose chest CT screening. The total number of lung cancer detected through the screening will be recorded

Countries

United States

Participant flow

Participants by arm

ArmCount
Low-dose CT Screening
Annual low-dose chest CT screening
39
Total39

Baseline characteristics

CharacteristicLow-dose CT Screening
Age, Categorical
<=18 years
0 Participants
Age, Categorical
>=65 years
2 Participants
Age, Categorical
Between 18 and 65 years
37 Participants
Age, Continuous51 years
Region of Enrollment
United States
39 participants
Sex: Female, Male
Female
16 Participants
Sex: Female, Male
Male
23 Participants

Adverse events

Event typeEG000
affected / at risk
deaths
Total, all-cause mortality
— / —
other
Total, other adverse events
0 / 39
serious
Total, serious adverse events
0 / 39

Outcome results

Primary

To Prospectively Collect Data on Chest CT Screening for Patients at Increase Lung-cancer Risk After Hodgkin's Disease.

In this study, patients will under annual low-dose chest CT screening. The total number of lung cancer detected through the screening will be recorded

Time frame: 3 years

Population: Enrolled patients who underwent low-dose CCT screening- number of lung cancer diagnosed

ArmMeasureValue (NUMBER)
Low-dose CT ScreeningTo Prospectively Collect Data on Chest CT Screening for Patients at Increase Lung-cancer Risk After Hodgkin's Disease.0 participants

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026